Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes

Cytokine

Volumn 56, Issue 2, 2011, Pages 376-386

  Tanigawa, Shihoko ^a   Aida, Yukiko ^a   Kawato, Takayuki ^a   Honda, Kazuhiro ^a   Nakayama, Go ^a   Motohashi, Masafumi ^a   Suzuki, Naoto ^a   Ochiai, Kuniyasu ^a   Matsumura, Hideo ^a   Maeno, Masao ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Chondrocyte; Interleukin 17; Matrix metalloproteinase; Prostaglandin E 2; Tissue inhibitor of metalloproteinase

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; COLLAGENASE; COLLAGENASE 3; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE A; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17 RECEPTOR B; INTERLEUKIN 17 RECEPTOR C; INTERLEUKIN 17 RECEPTOR D; INTERLEUKIN 17 RECEPTOR E; INTERLEUKIN 17F; INTERLEUKIN RECEPTOR; INTERSTITIAL COLLAGENASE; LINK PROTEIN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

BASE SEQUENCE; CARTILAGE; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; COLLAGENASES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-17; MATRIX METALLOPROTEINASE 3; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 80053336755     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.08.015     Document Type: Article

References (38)

1. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999, 103:1345-1352. 10.1172/JCI5703.
2. Kolls J.K., Lindén A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476. 10.1016/j.immuni.2004.08.01.
3. Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010, 129:311-321. 10.1111/j.1365-2567.2009.03240.x.
4. Moseley T.A., Haudenschild D.R., Rose L., Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003, 14:155-174. 10.1016/S1359-6101(03)00002-9.
5. Li H., Chen J., Huang A., Stinson J., Heldens S., Foster J., et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000, 97:773-778.
6. Lee J., Ho W.H., Maruoka M., Corpuz R.T., Baldwin D.T., et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001, 276:1660-1664. 10.1074/jbc.M008289200.
7. Starnes T., Robertson M.J., Sledge G., Kelich S., Nakshatri H., Broxmeyer H.E., et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001, 167:4137-4140.
8. Starnes T., Broxmeyer H.E., Robertson M.J., Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002, 169:642-646.
9. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001, 20:5332-5341. 10.1093/emboj/20.19.5332.
10. Zrioual S., Ecochard R., Tournadre A., Lenief V., Cazalis M., Miossec P. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 2009, 182:3112-3120.
11. + T cells. J Biol Chem 2007, 282:13447-13455. 10.1074/jbc.M700499200.
12. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995, 3:811-821. 10.1016/1074-7613(95)90070-5.
13. Ge D., You Z. Expression of interleukin-17RC protein in normal human tissues. Int Arch Med 2008, 1:19. 10.1186/1755-7682-1-19.
14. Zhang F., Wang C.L., Koyama Y., Mitsui N., Shionome C., Sanuki R., et al. Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells. Connect Tissue Res 2010, 51:359-369. 10.3109/03008200903456942.
15. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898.
16. Zhang F., Koyama Y., Sanuki R., Mitsui N., Suzuki N., Kimura A., et al. IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. Arch Oral Biol 2010, 55:679-688. 10.1016/j.archoralbio.2010.06.00.
17. Rengel Y., Ospelt C., Gay S. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther 2007, 9:221. 10.1186/ar2304.
18. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573. 10.1016/j.cardiores.2005.12.00.
19. Zhang F., Tanaka H., Kawato T., Kitami S., Nakai K., Motohashi M., et al. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Biochimie 2011, 93:296-305. 10.1016/j.biochi.2010.10.001.
20. O'Neill G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993, 330:156-160. 10.1016/0014-5793(93)80263-T.
21. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000/2007;43:85-101. doi:10.1111/j.1600-0757.2006.00170.x. doi:10.1111/j.1600-0757.2006.00170.x.
22. Kitami S., Tanaka H., Kawato T., Tanabe N., Katono-Tani T., Zhang F., et al. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 2010, 92:398-404. 10.1016/j.biochi.2009.12.01.
23. Shalom-Barak T., Quach J., Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998, 273:27467-27473. 10.1074/jbc.273.42.27467.
24. Koshy P.J., Henderson N., Logan C., Life P.F., Cawston T.E., Rowan A.D. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 2002, 61:704-713. 10.1136/ard.61.8.704.
25. Sylvester J., Liacini A., Li W.Q., Zafarullah M. Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell Signal 2004, 16:469-476. 10.1016/j.cellsig.2003.09.008.
26. Moran E.M., Mullan R., McCormick J., Connolly M., Sullivan O., Fitzgerald O., et al. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther 2009, 11:R113. 10.1186/ar277.
27. Kuboyama N., Zhao J., Zhang L., Suro T., Tanaka M., Sato M., et al. Effect of low level laser irradiation on CXCR3 gene expression in rheumatoid arthritis joint. J Hard Tissue Biol 2010, 19:141-146.
28. Honorati M.C., Meliconi R., Pulsatelli L., Canè S., Frizziero L., Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) 2001, 40:522-527. 10.1093/rheumatology/40.5.522.
29. Kokubu T., Haudenschild D.R., Moseley T.A., Rose L., Reddi A.H. Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. J Histochem Cytochem 2008, 56:89-95. 10.1369/jhc.7A7223.2007.
30. Goldring M.B., Marcu K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 2009, 11:224. 10.1186/ar2592.
31. Shi S., Grothe S., Zhang Y., O'Connor-McCourt M.D., Poole A.R., Roughley P.J., et al. Link protein has greater affinity for versican than aggrecan. J Biol Chem 2004, 279:12060-12066. 10.1074/jbc.M310091200.
32. Aida Y., Maeno M., Ito-Kato E., Suzuki N., Shiratsuchi H., Matsumura H. Effect of IL-1α on the expression of cartilage matrix proteins in human chondrosarcoma cell line OUMS-27. Life Sci 2004, 75:3173-3184.
33. Namba A., Aida Y., Suzuki N., Watanabe Y., Kawato T., Motohashi M., et al. Effects of IL-6 and soluble IL-6 receptor on the expression of cartilage matrix proteins in human chondrocytes. Connect Tissue Res 2007, 48:263-270.
34. Olson M.W., Gervasi D.C., Mobashery S., Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 1997, 272:29975-29983. 10.1074/jbc.272.47.29975.
35. Yu W.H., Yu S., Meng Q., Brew K., Woessner J.F. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000, 275:31226-31232. 10.1074/jbc.M000907200.
36. Huang W., Li W.Q., Dehnade F., Zafarullah M. Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 2002, 85:295-303. 10.1002/jcb.10138.
37. Aida Y., Maeno M., Suzuki N., Shiratsuchi H., Motohashi M., Matsumura H. The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sci 2005, 77:3210-3221.
38. Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008, 181:2799-2805.